104 related articles for article (PubMed ID: 2910307)
1. Effects of adriamycin and etoposide on the replication of adenovirus 5 in sensitive and resistant human tumour cells.
Parsons PG; Lean J; Khoo SK; Lark J
Biochem Pharmacol; 1989 Jan; 38(1):31-7. PubMed ID: 2910307
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity and cell cycle effects of platinum-based imaging agents in cisplatin-resistant human tumour cells.
Lean J; Parsons PG; Awaluddin AB; Jacobs JJ; Maddalena DJ; Wilson JG; Khoo SK; Ward C
Cancer Chemother Pharmacol; 1990; 26(1):42-6. PubMed ID: 2182213
[TBL] [Abstract][Full Text] [Related]
3. Effects of antimetabolites on adenovirus replication in sensitive and resistant human melanoma cell lines.
Musk P; Stowers A; Parsons PG
Biochem Pharmacol; 1990 Feb; 39(4):631-7. PubMed ID: 1689577
[TBL] [Abstract][Full Text] [Related]
4. Relationship of DNA topoisomerase II alpha and beta expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell lines.
Brown GA; McPherson JP; Gu L; Hedley DW; Toso R; Deuchars KL; Freedman MH; Goldenberg GJ
Cancer Res; 1995 Jan; 55(1):78-82. PubMed ID: 7805045
[TBL] [Abstract][Full Text] [Related]
5. Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells.
Yang HL; Dong YB; Elliott MJ; Wong SL; McMasters KM
Cancer Gene Ther; 2001 Apr; 8(4):241-51. PubMed ID: 11393276
[TBL] [Abstract][Full Text] [Related]
6. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line.
de Jong S; Zijlstra JG; de Vries EG; Mulder NH
Cancer Res; 1990 Jan; 50(2):304-9. PubMed ID: 1967222
[TBL] [Abstract][Full Text] [Related]
7. Relationships between resistance to cross-linking agents and glutathione metabolism, aldehyde dehydrogenase isozymes and adenovirus replication in human tumour cell lines.
Parsons PG; Lean J; Kable EP; Favier D; Khoo SK; Hurst T; Holmes RS; Bellet AJ
Biochem Pharmacol; 1990 Dec; 40(12):2641-9. PubMed ID: 2260988
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
Dong YB; Yang HL; Elliott MJ; McMasters KM
Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154
[TBL] [Abstract][Full Text] [Related]
9. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin.
Meng RD; Phillips P; El-Deiry WS
Int J Oncol; 1999 Jan; 14(1):5-14. PubMed ID: 9863003
[TBL] [Abstract][Full Text] [Related]
10. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
[TBL] [Abstract][Full Text] [Related]
11. Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors.
Ades S; Maxfield LF; Gould CJ; Jones GK; Levy SB
Int J Oncol; 2006 Mar; 28(3):747-53. PubMed ID: 16465381
[TBL] [Abstract][Full Text] [Related]
12. Differential stabilization of topoisomerase-II-DNA cleavable complexes by doxorubicin and etoposide in doxorubicin-resistant rat glioblastoma cells.
Montaudon D; Pourquier P; Denois F; de Tinguy-Moreaud E; Lagarde P; Robert J
Eur J Biochem; 1997 Apr; 245(2):307-15. PubMed ID: 9151958
[TBL] [Abstract][Full Text] [Related]
13. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Goldenberg GJ; Wang H; Blair GW
Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
[TBL] [Abstract][Full Text] [Related]
14. Trifluoperazine modulation of resistance to the topoisomerase II inhibitor etoposide in doxorubicin resistant L1210 murine leukemia cells.
Kamath N; Grabowski D; Ford J; Drake F; Kerrigan D; Pommier Y; Ganapathi R
Cancer Commun; 1991 Feb; 3(2):37-44. PubMed ID: 1995027
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus replication as an in vitro probe for drug sensitivity in human tumors.
Parsons PG; Maynard KR; Little JH; McLeod GR
Eur J Cancer Clin Oncol; 1986 Apr; 22(4):401-9. PubMed ID: 3525182
[TBL] [Abstract][Full Text] [Related]
16. Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection: decreased anthracycline uptake precedes increased P-glycoprotein expression.
Slapak CA; Daniel JC; Levy SB
Cancer Res; 1990 Dec; 50(24):7895-901. PubMed ID: 1979251
[TBL] [Abstract][Full Text] [Related]
17. Determinants of response to the DNA topoisomerase II inhibitors doxorubicin and etoposide in human lung cancer cell lines.
Kasahara K; Fujiwara Y; Sugimoto Y; Nishio K; Tamura T; Matsuda T; Saijo N
J Natl Cancer Inst; 1992 Jan; 84(2):113-8. PubMed ID: 1310509
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic interactions between stathmin inhibition and chemotherapeutic agents in prostate cancer.
Mistry SJ; Atweh GF
Mol Cancer Ther; 2006 Dec; 5(12):3248-57. PubMed ID: 17172428
[TBL] [Abstract][Full Text] [Related]
19. A short-term in vitro test for tumour sensitivity to adriamycin based on flow cytometric DNA analysis.
Engelholm SA; Spang-Thomsen M; Vindeløv LL
Br J Cancer; 1983 Apr; 47(4):497-502. PubMed ID: 6849794
[TBL] [Abstract][Full Text] [Related]
20. Cross-sensitivity of methylating agents, hydroxyurea, and methotrexate in human tumor cells of the Mer- phenotype.
Maynard K; Parsons PG
Cancer Res; 1986 Oct; 46(10):5009-13. PubMed ID: 3756862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
